Cantor Fitzgerald Has Weak Forecast for AXSM FY2026 Earnings

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Stock analysts at Cantor Fitzgerald decreased their FY2026 earnings per share (EPS) estimates for Axsome Therapeutics in a note issued to investors on Tuesday, September 16th. Cantor Fitzgerald analyst P. Stavropoulos now forecasts that the company will post earnings per share of ($2.54) for the year, down […]

Leave a Reply

Your email address will not be published.

Previous post Q2 EPS Estimates for Caterpillar Boosted by Zacks Research
Next post Roth Capital Has Positive Forecast for Kroger Q3 Earnings